CNC vs SLS · P/E 8.4, rev $103.52B vs $1.62B cap
Centene Corp (CNC) versus Sellas Life Sciences Group Inc (SLS) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Sellas Life Sciences Group Inc (SLS) is a biotechnology company listed on US.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported SLS revenue for 2026-06-30 was $0. Net income was -$18.0M. SLS currently screens at market cap $1.62B.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. SLS currently screens at market cap $1.62B.
Not investment advice. Open the CNC and SLS stock pages for the full models.
Not investment advice.